C. Mathis

W. Jagust, B. Reed, C. Mathis, 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy

Keith A. Johnson, D. Salat, A. Fischman, 2007, Annals of neurology.

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Paul Maruff, Greg Savage, Christopher C Rowe, 2007, Brain : a journal of neurology.

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

S. DeKosky, W. Klunk, C. Mathis, 2008, Brain : a journal of neurology.

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

Cindee M. Madison, M. Weiner, B. Miller, 2009, Brain : a journal of neurology.

Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue

Keith A. Johnson, B. Dickerson, J. Growdon, 2015, Annals of neurology.

Reduced binding of Pittsburgh Compound-B in areas of white matter hyperintensities

D. Minhas, O. Lopez, W. Klunk, 2015, NeuroImage: Clinical.

Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease

Alan C. Evans, Sterling C. Johnson, Keith A. Johnson, 2019, bioRxiv.

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.

N. Bohnen, S. DeKosky, R. Koeppe, 2003, Archives of neurology.

Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia

N. Bohnen, S. DeKosky, C. Mathis, 2006, Journal of Neurology.

Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects.

W. Klunk, C. Mathis, J. Price, 2014, Brain : a journal of neurology.

Imaging Amyloid-β Deposits In Vivo

B. Hyman, W. Klunk, C. Mathis, 2002 .

Imaging amyloid-beta deposits in vivo.

B. Hyman, W. Klunk, C. Mathis, 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.

W. Klunk, C. Mathis, Yanming Wang, 2001, Life sciences.

Imaging β-amyloid burden in aging and dementia

C. Rowe, W. Klunk, C. Masters, 2007, Neurology.

Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease

Nick C Fox, Keith A. Johnson, Christopher J. Owen, 2013, Proceedings of the National Academy of Sciences.

Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography.

B. Hyman, W. Klunk, C. Mathis, 2003, Neuroimaging clinics of North America.

Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain

S. DeKosky, W. Klunk, C. Mathis, 2005, The Journal of Neuroscience.

Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B

S. DeKosky, W. Klunk, C. Mathis, 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

Gina N. LaRossa, A. Fagan, A. Shah, 2006, Annals of neurology.

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

B. Miller, W. Jagust, W. Klunk, 2007, Neurology.

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.

Keith A. Johnson, J. Growdon, B. Hyman, 2007, Archives of neurology.

Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

G. Alexander, S. DeKosky, W. Klunk, 2009, Proceedings of the National Academy of Sciences.

Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer's Disease

W. Klunk, C. Mathis, C. Sorg, 2010, Biological Psychiatry.

Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease

Keith A. Johnson, J. Morris, C. Jack, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

W. Klunk, C. Mathis, Yanming Wang, 2003, Journal of medicinal chemistry.

Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve

Bedda L. Rosario, Jeffrey A. James, S. DeKosky, 2009, The Journal of Neuroscience.

Amyloid imaging in mild cognitive impairment subtypes

Jeffrey A. James, O. Lopez, S. DeKosky, 2009, Annals of neurology.

Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults

L. Kuller, O. Lopez, S. DeKosky, 2013, Neurology.

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer’s disease

N. Bohnen, S. DeKosky, R. Koeppe, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Nick C Fox, 2016, Scientific Reports.

The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015

W. Jagust, R. Koeppe, C. Mathis, 2015, Alzheimer's & Dementia.

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Norbert Schuff, Robert C. Green, Andrew J. Saykin, 2017, Scientific Reports.

β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

Paul Maruff, Colin L. Masters, William E. Klunk, 2007 .

Altered 5-HT2A Receptor Binding after Recovery from Bulimia-Type Anorexia Nervosa: Relationships to Harm Avoidance and Drive for Thinness

Lisa Weissfeld, Julie C Price, Carolyn C Meltzer, 2004, Neuropsychopharmacology.

Potential antecedent marker of Alzheimer disease

Yvette I. Sheline, Chester A. Mathis, S. Y. Lee, 2006 .

Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder.

Norbert Schuff, Clifford R Jack, Mark D'Esposito, 2009, Journal of rehabilitation research and development.

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease

Hiroto Kuwabara, Nicolaas I. Bohnen, Chester A. Mathis, 2007, Journal of Neurology.

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Nature Communications.

PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET

William E. Klunk, Chester A. Mathis, Ronald L. Hamilton, 2009, Neurobiology of Aging.

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

Julie Price, S. DeKosky, W. Klunk, 2009, Archives of neurology.

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice

Brian J Bacskai, Guo-Feng Huang, Gregory A. Hickey, 2003, Proceedings of the National Academy of Sciences of the United States of America.

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain.

Brian J Bacskai, Guo-Feng Huang, Matthew P Frosch, 2002, Bioorganic & medicinal chemistry letters.

P2-031 Amyloid deposits in transgenic PS1/APP mice do not bind the amyloid pet tracer, PIB, in the same manner as human brain amyloid

S. DeKosky, W. Klunk, C. Mathis, 2004, Neurobiology of Aging.

Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa

N. Schork, A. Gamst, C. Mathis, 2013, Psychiatry Research: Neuroimaging.

Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies.

Julie C Price, S. DeKosky, W. Klunk, 2005, Archives of neurology.

Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques

L. Ferrucci, S. Resnick, C. Davatzikos, 2012, Acta Neuropathologica.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology

Sterling C. Johnson, David T. Jones, Taylor W. Schmitz, 2016, Nature Communications.

Development and Application of b-Amyloid Imaging Agents in Alzheimer’s Disease

S. DeKosky, W. Klunk, C. Mathis, 2016 .

Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities

W. Klunk, C. Mathis, J. Price, 2013, Neuropsychologia.

Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease

Hiroto Kuwabara, Nicolaas I. Bohnen, Chester A. Mathis, 2007, Neuroscience Letters.

CHAPTER 16 – Scatter Correction for Brain Receptor Quantitation in 3D PET

Donald Sashin, David W. Townsend, Paul E. Kinahan, 1996 .

Amyloid deposition is associated with different patterns of hippocampal connectivity in men versus women

W. Klunk, C. Mathis, B. Snitz, 2019, Neurobiology of Aging.

Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [11C]ABP688

J. Mann, R. Parsey, C. Mathis, 2015, Translational Psychiatry.

Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2020, Scientific Reports.

Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease

W. Klunk, C. Mathis, C. Buckley, 2020, Acta Neuropathologica.

Evaluation of reference tissue models for quantification of [11C] Pittsburgh compound B dynamic PET studies

Susan M. Resnick, Yun Zhou, Weiguo Ye, 2006 .

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen

Sterling C. Johnson, Matthew D. Zammit, C. Laymon, 2020, Alzheimer's & dementia.

Arterial stiffness and β-amyloid progression in nondemented elderly adults.

L. Kuller, O. Lopez, S. DeKosky, 2014, JAMA neurology.

Relationships Between Executive Control Circuit Activity, Amyloid Burden, and Education in Cognitively Healthy Older Adults.

W. Klunk, C. Mathis, J. Price, 2019, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Statistical Methods for Processing Neuroimaging Data from Two Different Sites with a Down Syndrome Population Application

Sterling C. Johnson, Ciprian M. Crainiceanu, John Muschelli, 2020, IPMU.

Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

W. Jagust, W. Klunk, C. Mathis, 2012, Advances in pharmacology.

Relationship of amyloid-β1–42 in blood and brain amyloid: Ginkgo Evaluation of Memory Study

L. Kuller, O. Lopez, W. Klunk, 2019, Brain communications.

Evidence of increased serotonin-1A receptor binding in type 2 diabetes: a positron emission tomography study

Sati Mazumdar, Carolyn C. Meltzer, Charles F. Reynolds, 2002, Brain Research.

Heritability of regional brain volumes in large-scale neuroimaging and genetic studies

David T. Jones, Nick C Fox, M. Albert, 2017, bioRxiv.

Quantitative assessment of glucose transport in human skeletal muscle: dynamic positron emission tomography imaging of [O-methyl-11C]3-O-methyl-D-glucose.

Alessandra Bertoldo, Claudio Cobelli, Carol Kelley, 2005, The Journal of clinical endocrinology and metabolism.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2019, Nature Communications.

Synthesis and 11C-labelling of (E,E)-1-(3′,4′-dihydroxystyryl)-4-(3′-methoxy-4′-hydroxystyryl) benzene for PET imaging of amyloid deposits††

W. Klunk, C. Mathis, Yanming Wang, 2002 .

Markers of cholesterol transport are associated with amyloid deposition in the brain

J. Williamson, L. Kuller, O. Lopez, 2014, Neurobiology of Aging.

Joint‐label fusion brain atlases for dementia research in Down syndrome

D. Minhas, A. Fagan, N. Tustison, 2022, Alzheimer's & dementia.

[18F]FDG, [11C]PiB, and [18F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline

D. Minhas, J. Mountz, C. Laymon, 2019, Front. Neurol..

The Relationship of Current Cognitive Activity to Brain Amyloid Burden and Glucose Metabolism.

D. Minhas, O. Lopez, C. Laymon, 2018, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

David T. Jones, Keith A. Johnson, Jeffrey N. Browndyke, 2018, Anesthesiology.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2020, Nature Communications.

Title Large-scale genomics unveil polygenic architecture of human cortical surface area Permalink

Devon, David T. Jones, Frank, 2015 .

Sleep moderates the relationship between amyloid beta and memory recall

Daniel J Buysse, Kristine A. Wilckens, D. Minhas, 2018, Neurobiology of Aging.

Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia

C. Mathis, R. Narendran, N. Mason, 2022, Biological Psychiatry.

[18F]Altanserin PET Studies of Serotonin-2A Binding: Examination of Nonspecific Component

Gwenn S. Smith, Yiyun Huang, C. Mathis, 1998 .

Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging

A. Saykin, S. Risacher, O. Lopez, 2018, Molecular Psychiatry.

Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition

W. Klunk, E. McDade, C. Mathis, 2018, Alzheimer's & Dementia.

In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.

C. Mathis, J. Price, R. Narendran, 2012, The American journal of psychiatry.

Amphetamine-Induced Dopamine Release Greater in Ventral Than in Dorsal Striatum

Paul Kinahan, W. Drevets, C. Mathis, 2001 .

Amyloid-Beta Deposition is Associated with Increased Medial Temporal Lobe Activation during Memory Encoding in the Cognitively Normal Elderly.

W. Klunk, C. Mathis, J. Price, 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Small-molecule PET Tracers for Imaging Proteinopathies.

W. Klunk, C. Mathis, B. Lopresti, 2017, Seminars in nuclear medicine.

Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population

Sterling C. Johnson, Bradley T. Christian, William E. Klunk, 2017, Alzheimer's & dementia.

Amyloid accumulation in Down syndrome measured with amyloid load

Sterling C. Johnson, Matthew D. Zammit, D. Minhas, 2020, Alzheimer's & dementia.

Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.

Sterling C. Johnson, Patrick J. Lao, W. Klunk, 2017, Journal of Alzheimer's disease : JAD.

The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11–labeled Pittsburgh compound B

Sterling C. Johnson, Regina M. Hardison, Patrick J. Lao, 2016, Alzheimer's & Dementia.

Amyloid burden and neural function in people at risk for Alzheimer's Disease

Sterling C. Johnson, Barbara B. Bendlin, Bradley T. Christian, 2014, Neurobiology of Aging.

In Vivo Fibrillar (cid:2) -Amyloid Detected Using [ 11 C]PiB Positron Emission Tomography and Neuropathologic Assessment in Older Adults

L. Ferrucci, S. Resnick, M. Kraut, 2011 .

Amyloid imaging with Pittsburgh Compound B

S. DeKosky, W. Klunk, C. Mathis, 2005, Alzheimer's & Dementia.

LONGITUDINAL CHANGE OF NEUROIMAGING AND CLINICAL MARKERS IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE

O. Lopez, W. Klunk, E. McDade, 2014, Alzheimer's & Dementia.

EFFECTS OF SOY ISOFLAVONES ON COGNITIVE FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

L. Kuller, C. Mathis, B. Snitz, 2018, Alzheimer's & Dementia.

Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load

D. Minhas, O. Lopez, C. Laymon, 2018, NeuroImage: Clinical.

Binding Potency of 6‐Nitroquipazine Analogues for the 5‐Hydroxytryptamine Reuptake Complex

C. Mathis, C. Mathis, S. E. Taylor, 1994, The Journal of pharmacy and pharmacology.

Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?

Susan M Resnick, Luigi Ferrucci, Michael A Kraut, 2008, Journal of Nuclear Medicine.

Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases

Sterling C. Johnson, Nick C Fox, Keith A. Johnson, 2012, Neurology.

IC-P-127 Non-invasive early detection of beta-amyloid molecular pathology by quasi-elastic light scattering in vivo

John I. Clark, W. Klunk, C. Mathis, 2006, Alzheimer's & Dementia.

Development of Benzothiazole Amyloid-Imaging Agents

W. Klunk, C. Mathis, Yanming Wang, 2004 .

Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Scientific Reports.

In Pre-Clinical AD Small Vessel Disease is Associated With Altered Hippocampal Connectivity and Atrophy.

W. Klunk, C. Mathis, B. Snitz, 2022, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

P2-366 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

Keith A. Johnson, D. Pollen, A. Fischman, 2006, Alzheimer's & Dementia.

11C-PIB PET imaging in the differential diagnosis of dementia

C. Rowe, W. Klunk, C. Masters, 2006 .

Optimal time window for standardized uptake ratio as a simplified measure of PIB retension

S. DeKosky, W. Klunk, C. Mathis, 2007 .

Imaging amyloid deposition in Lewy body diseases

Keith A. Johnson, J. Growdon, B. Hyman, 2008, Neurology.

The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component

William E. Klunk, Chester A. Mathis, Daniel P. Holt, 2003, The Journal of Neuroscience.

Arterial stiffness is associated with amyloid deposition in the brain independent of blood pressure

L. Kuller, O. Lopez, S. DeKosky, 2013, Alzheimer's & Dementia.

O3-03-05 Human amyloid-imaging studies in controls, mild cognitive impairment and Alzheimer's disease using Pittsburg compound-B

S. DeKosky, W. Klunk, C. Mathis, 2004, Neurobiology of Aging.

[F‐18]AV‐1451 positron emission tomography retention in choroid plexus: More than “off‐target” binding

W. Klunk, C. Mathis, J. Price, 2016, Annals of neurology.

P2-178 Species-dependent formation and identification of the brain metabolites of the amyloid imaging agent [11C]PIB

W. Klunk, C. Mathis, Yanming Wang, 2004, Neurobiology of Aging.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

Norbert Schuff, Adrian Preda, John Kornak, 2012, Proceedings of the National Academy of Sciences.

Alzheimer research forum live discussion: Imaging in Alzheimer's disease: the current state of affairs.

Nick C Fox, Keith A. Johnson, Betty K. Tuller, 2005, Journal of Alzheimer's disease : JAD.

Synthesis of 123I‐and labelled 5‐iodo‐6‐nitroquipazine

C. Mathis, S. Hanrahan, E. Akgün, 1994 .

Chapter 39 – Imaging Inflammation

C. Mathis, B. Lopresti, N. Mason, 2005 .

High pressure nucleophilic fluoride-ion substitution reactions: formation of fluoroalkylbenzenes

C. Mathis, J. Gerdes, A. Shulgin, 1996 .

Direct Comparison of the Tau PET Tracers 18F-Flortaucipir and 18F-MK-6240 in Human Subjects

D. Minhas, J. Mountz, O. Lopez, 2021, The Journal of Nuclear Medicine.

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization

Keith A. Johnson, Raymond Scott Turner, Joanne L. Lord, 2021, Scientific Reports.

Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study

Chester A. Mathis, Wayne C. Drevets, Sarah L. Berga, 2000, Biological Psychiatry.

Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals.

Jeffrey A. James, D. Minhas, O. Lopez, 2015, JAMA neurology.

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

Robert A. Koeppe, Keith A. Johnson, William E. Klunk, 2015, Alzheimer's & Dementia.

Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease

Jeffrey A. James, D. Minhas, J. Becker, 2014, Neurology.

PiB and structural MRI provide complementary information in imaging of Alzheimer ’ s disease and amnestic mild cognitive impairment

C. Jack, R. Petersen, B. Boeve, 2008 .

dominant Alzheimer disease Cerebral perfusion alterations and cerebral amyloid in autosomal

Jeffrey A. James, D. Minhas, J. Becker, 2022 .

Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches

Lisa A. Weissfeld, Oscar L. Lopez, Howard Aizenstein, 2013, NeuroImage.

Development of a PET/SPECT agent for amyloid imaging in Alzheimer’s disease

William E. Klunk, Chester A. Mathis, Daniel P. Holt, 2007, Journal of Molecular Neuroscience.

Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives

William E. Klunk, Chester A. Mathis, Daniel P. Holt, 2007, Journal of Molecular Neuroscience.

Imaging β-Amyloid Plaques and Neurofibrillary Tangles in the Aging Human Brain

W. Klunk, C. Mathis, Yanming Wang, 2004 .

Measurement of 5‐HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY‐100635

D. Kupfer, M. Thase, W. Drevets, 2007, Synapse.

Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy‐X04, a Systemically Administered Congo Red Derivative

B. Hyman, M. Frosch, W. Klunk, 2002, Journal of neuropathology and experimental neurology.

Development of positron emission tomography β-amyloid plaque imaging agents.

W. Klunk, C. Mathis, B. Lopresti, 2012, Seminars in nuclear medicine.

Clinical Studies of Cerebral Blood Flow in Alzheimer's Disease

W. Jagust, B. Reed, C. Mathis, 1997, Annals of the New York Academy of Sciences.

Regional cerebral glucose transport and utilization in Alzheimer's disease

W. Jagust, B. Mazoyer, C. Mathis, 1989, Neurology.

Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose

R H Huesman, C. Mathis, R. Huesman, 1983, Journal of computer assisted tomography.

Dynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance

F. Haiss, W. Klunk, C. Mathis, 2008, The Journal of Neuroscience.

Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders

C. Mathis, R. Narendran, B. Lopresti, 2022, Journal of neurochemistry.

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome

C. Laymon, W. Klunk, C. Mathis, 2021, NeuroImage.

Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study

Peter J Gianaros, Jeffrey A. James, Lisa Weissfeld, 2015, The Lancet Neurology.

Serotonin alterations in anorexia and bulimia nervosa: New insights from imaging studies

Carolyn C. Meltzer, Chester A. Mathis, Julie C. Price, 2005, Physiology & Behavior.

Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B

W. Klunk, C. Mathis, J. Price, 2012, Alzheimer's & Dementia.

Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging

D. Kupfer, Gwenn S. Smith, B. Pollock, 1998, Neuropsychopharmacology.

Large-scale genomics unveil polygenic architecture of human cortical surface area

Norbert Schuff, Anders M. Dale, Robert C. Green, 2015, Nature Communications.

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Nick C Fox, Robert Koeppe, Jianing Di, 2015, Neurology.

Longitudinal in vivo positron emission tomography imaging of infected and activated brain macrophages in a macaque model of human immunodeficiency virus encephalitis correlates with central and peripheral markers of encephalitis and areas of synaptic degeneration.

C. Mathis, B. Lopresti, J. Lifson, 2008, The American journal of pathology.

Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults.

Oscar L Lopez, Julie C Price, Eric McDade, 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease

Yun Zhou, Susan M. Resnick, Dean F. Wong, 2007, NeuroImage.

Tenascin-C Is Associated with Cored Amyloid-&bgr; Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly

William E. Klunk, Chester A. Mathis, Eric E. Abrahamson, 2016, Journal of neuropathology and experimental neurology.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Keith A. Johnson, Charles D. Smith, Sherye A. Sirrel, 2020, Nature Communications.

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain.

Chester A. Mathis, B. Hyman, M. Frosch, 2002, Bioorganic & medicinal chemistry letters.

Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies

Keith A. Johnson, Matthew P Frosch, Derek H. Oakley, 2017, Annals of neurology.

Targeting Prion Amyloid Deposits In Vivo

W. Gan, W. Klunk, C. Mathis, 2004, Journal of neuropathology and experimental neurology.

Stereoconservative synthesis of the enantiomerically pure precursors of [11C](+)-McN 5652 and [11C](-)-McN 5652

Yiyun Huang, C. Mathis, N. Mason, 1998 .

Amyloid Imaging with PET in Alzheimer’s Disease, Mild Cognitive Impairment, and Clinically Unimpaired Subjects

S. DeKosky, W. Klunk, C. Mathis, 2009 .

Impact of amyloid imaging on drug development in Alzheimer's disease.

W. Klunk, C. Mathis, B. Lopresti, 2007, Nuclear medicine and biology.

Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice.

D. Holtzman, B. Hyman, S. Paul, 2005, The Journal of clinical investigation.

In Vivo Imaging of Alzheimer Pathology in Transgenic Mice using Multiphoton Microscopy

Gregory A. Hickey, B. Hyman, M. Frosch, 2004 .

X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.

S. DeKosky, W. Klunk, C. Mathis, 2006, Methods in enzymology.

Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.

Young T. Hong, J. Baron, J. Pickard, 2014, JAMA neurology.

SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0

Koen Van Laere, Osama Sabri, Chester A. Mathis, 2016, The Journal of Nuclear Medicine.

Comparison of longitudinal Aβ in nondemented elderly and Down syndrome

Sterling C. Johnson, Charles M. Laymon, Ann D. Cohen, 2019, Neurobiology of Aging.

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome

Sterling C. Johnson, Matthew D. Zammit, M. Sabbagh, 2021, NeuroImage: Clinical.

Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

C. Jack, C. DeCarli, R. Petersen, 2018, Alzheimer's & Dementia.

Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality

J. Becker, L. Kuller, O. Lopez, 2018, Neurology.

Amyloid imaging in dementias with atypical presentation

S. DeKosky, W. Klunk, C. Mathis, 2012, Alzheimer's & Dementia.

Tau imaging : pathologic correlations 3 Number of words in the body of the manuscript : 3535 Number of figures : 5 Number of color figures : 4 Number of tables : 0

Derek H. Oakley, B. Hyman, M. Frosch, 2016 .

Positron Emission Tomography Agents for Central Nervous System Drug Development Applications

C. Mathis, N. Mason, 2005 .

Radiohalogens for PET Imaging

C. Mathis, N. Mason, 2005 .

Positron emission tomography radiochemistry.

C. Mathis, N. Mason, 2003, Neuroimaging clinics of North America.

The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods

Bradley T. Christian, Charles M. Laymon, Ann D. Cohen, 2018, Alzheimer's & dementia.

Why we need two cutoffs for amyloid imaging: Early versus Alzheimer's-like amyloid-positivity

Howard Aizenstein, Lisa Weissfeld, Chester Mathis, 2012, Alzheimer's & Dementia.

A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old

J. Becker, L. Kuller, O. Lopez, 2014, Neurology.

Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories

D. Minhas, O. Lopez, W. Klunk, 2020, Neurobiology of Aging.

Imaging Alzheimer Pathology in Late-Life Depression With PET and Pittsburgh Compound-B

C. Reynolds, S. DeKosky, W. Klunk, 2008, Alzheimer disease and associated disorders.

Positron emission tomography radioligands for in vivo imaging of Aβ plaques.

W. Klunk, C. Mathis, N. Mason, 2013, Journal of labelled compounds & radiopharmaceuticals.

In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects

Lewis H Kuller, Oscar L Lopez, Bedda L. Rosario, 2013, Annals of neurology.

Development of a PET radioligand selective for cerebral amyloid angiopathy.

W. Klunk, C. Mathis, A. Vazquez, 2020, Nuclear medicine and biology.

Amyloid &bgr; Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia

L. Kuller, O. Lopez, S. DeKosky, 2018, JAMA neurology.

Cerebral Amyloid Deposition and Dual-Tasking in Cognitively Normal, Mobility Unimpaired Older Adults

S. Studenski, M. Redfern, O. Lopez, 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study.

J. Becker, O. Lopez, W. Klunk, 2015, Journal of Alzheimer's disease : JAD.

Imaging Tau Deposits In Vivo: Progress in Viewing More of The Proteopathy Picture

W. Klunk, C. Mathis, 2013, Neuron.

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease

Markus Schwaiger, William E. Klunk, Chester A. Mathis, 2008, NeuroImage.

11 CPIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

B. L. Miller, W. Jagust, W. Klunk, 2007 .

Association of plasma and cortical amyloid beta is modulated by APOE ε4 status

M. Weiner, R. Petersen, W. Jagust, 2014, Alzheimer's & Dementia.

Association of plasma and cortical beta-amyloid is modulated by APOE ε4 status.

M. Weiner, R. Petersen, W. Jagust, 2014 .

In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.

Susan M Resnick, Luigi Ferrucci, Michael A Kraut, 2011, Archives of neurology.

Association of Brain Amyloid-&bgr; With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E &egr;4 Genotype

J. Williamson, O. Lopez, S. DeKosky, 2017, JAMA neurology.

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Julie C Price, S. DeKosky, W. Klunk, 2006, Brain : a journal of neurology.

Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects

James M. Mountz, Charles M. Laymon, Ann D. Cohen, 2015, NeuroImage: Clinical.

Consideration of Optimal Time Window for Pittsburgh Compound B PET Summed Uptake Measurements

Bedda L. Rosario, S. DeKosky, W. Klunk, 2009, Journal of Nuclear Medicine.

Design, synthesis and structure-activity relationship of rhenium 2-arylbenzothiazoles as β-amyloid plaque binding agents.

W. Klunk, C. Mathis, M. Debnath, 2013, Bioorganic & medicinal chemistry letters.

The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation

William E. Klunk, Chester A. Mathis, W. Klunk, 2008, Current opinion in neurology.

Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment

S. Wisniewski, J. Becker, O. Lopez, 2006, Journal of NeuroVirology.

Imaging of dopamine D2/3 agonist binding in cocaine dependence: A [11C]NPA positron emission tomography study

C. Mathis, J. Price, R. Narendran, 2011, Synapse.

Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals

Christos Davatzikos, Susan M. Resnick, Luigi Ferrucci, 2011, Neurobiology of Aging.

Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease

Lisa A. Weissfeld, William E. Klunk, Chester A. Mathis, 2006, NeuroImage.

b -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease

Simon A. Moss, Paul Maruff, Colin L. Masters, 2007 .

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection

W. Klunk, C. Mathis, Colin Smith, 2016, Acta neuropathologica communications.

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

Sterling C. Johnson, John X. Morris, Omar H. Butt, 2023, The Lancet Neurology.

Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia

C. Mathis, R. Narendran, N. Mason, 2017, Biological Psychiatry.

INCREASES IN PIB RETENTION ARE ASSOCIATED WITH INCREASED CEREBRAL GLUCOSE METABOLISM IN COGNITIVELY NORMAL ELDERLY: ROLE FOR COMPENSATORY HYPERMETABOLISM?

W. Klunk, C. Mathis, J. Price, 2016, Alzheimer's & Dementia.

Preventive immunization of aged and juvenile non-human primates to beta-amyloid

Colin R. Janssen, E. Masliah, C. Mathis, 2012, Journal of Neuroinflammation.

Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression

Sati Mazumdar, Julie C Price, Carolyn Cidis Meltzer, 2004, Neuropsychopharmacology.

Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women

A. Hariri, C. Mathis, J. Price, 2005, Molecular Psychiatry.

Functional connectivity in autosomal dominant and late-onset Alzheimer disease.

Sebastien Ourselin, Clifford R Jack, Chengjie Xiong, 2014, JAMA neurology.

Low untreated systolic blood pressure over 18 years is associated with survival free of dementia age 90+

L. Kuller, C. Mathis, B. Snitz, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease

S. DeKosky, W. Klunk, C. Mathis, 2011, Neurology.

Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease

N. Bohnen, S. DeKosky, C. Mathis, 2005, Neuroscience Letters.

An Effect of Education on Memory-Encoding Activation in Subjective Cognitive Decline.

W. Klunk, C. Mathis, B. Snitz, 2021, Journal of Alzheimer's disease : JAD.

[11C]flumazenil Binding Is Increased in a Dose-Dependent Manner with Tiagabine-Induced Elevations in GABA Levels

W. Gordon Frankle, Chester A. Mathis, Rajesh Narendran, 2012, PloS one.

Imaging of CNS myelin by positron-emission tomography.

W. Klunk, C. Mathis, Guo-feng Huang, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Cortical cholinergic denervation is associated with depressive symptoms in Parkinson’s disease and parkinsonian dementia

N. Bohnen, C. Mathis, D. Kaufer, 2007, Journal of Neurology, Neurosurgery & Psychiatry.

5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups.

N. Schork, M. Geyer, C. Mathis, 2011, The International journal of eating disorders.

Gender-specific aging effects on the serotonin 1A receptor

Chester A. Mathis, Julie C. Price, Wayne C. Drevets, 2001, Brain Research.

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B

James T. Becker, William E. Klunk, Chester A. Mathis, 2008, Journal of Neuroscience Methods.

Comparing Pathological Risk Factors for Dementia between Cognitively Normal Japanese and Americans

L. Kuller, O. Lopez, W. Klunk, 2021, Brain sciences.

Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia

L. Kuller, O. Lopez, S. DeKosky, 2013, Neurology.

Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study

O. Lopez, S. DeKosky, W. Klunk, 2012, Acta Neuropathologica.

The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: Implications for PET imaging

Chester A. Mathis, Clayton A. Wiley, Brian J. Lopresti, 2007, Experimental Neurology.

Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort

Karmen K. Yoder, C. Jack, M. Weiner, 2011, Brain Imaging and Behavior.

Associations of equol‐producing status with white matter lesion and amyloid‐β deposition in cognitively normal elderly Japanese

L. Kuller, O. Lopez, W. Klunk, 2020, Alzheimer's & dementia.

Development and Screening of Contrast Agents for In Vivo Imaging of Parkinson’s Disease

W. Klunk, C. Mathis, B. Bacskai, 2013, Molecular Imaging and Biology.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

György J. Simon, David T. Jones, Keith A. Johnson, 2020, Scientific Reports.

Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET

Lisa A. Weissfeld, Bedda L. Rosario, Charles M. Laymon, 2010, NeuroImage.

Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies.

W. Klunk, C. Mathis, J. Sandell, 2021, ACS chemical neuroscience.

Direct Correlations of [H-3]Flutemetamol Binding with [H-3]PiB Binding and Amyloid-beta Concentration and Plaque Load in [C-11]PiB Imaged Brains (S34.002)

W. Klunk, C. Mathis, J. Price, 2012 .

Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals

W. Klunk, C. Mathis, B. Snitz, 2019, The Journals of Gerontology: Series A.

Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice.

S. DeKosky, W. Klunk, C. Mathis, 2009, Letters in drug design & discovery.

In vivo evaluation and imaging of a lipophilic derivative of Congo red for amyloid assessments

B. Hyman, W. Klunk, C. Mathis, 2001 .

Lipophilic 11C‐labelled thioflavin‐T analogues for imaging amyloid plaques in alzheimer's disease

W. Klunk, C. Mathis, Yanming Wang, 2001 .

Whatever happened to Pittsburgh Compound-A?

W. Klunk, C. Mathis, 2008, Alzheimer disease and associated disorders.

PiB PET/CT identification of meningiomas is not due to presence of amyloid-beta within tumors

V. Lowe, J. Parisi, C. Mathis, 2012 .

In vivo amyloid deposition and neuropathological findings after humanized amyloid β-specific monoclonal antibodies therapy in a patient with Alzheimer's disease

J. Becker, O. Lopez, S. DeKosky, 2009, Alzheimer's & Dementia.

Human Biodistribution and Dosimetry of the D2/3 Agonist 11C-N-Propylnorapomorphine (11C-NPA) Determined from PET

J. Mountz, C. Laymon, C. Mathis, 2009, Journal of Nuclear Medicine.

An Aβ Sequestration Approach Using Non-Antibody Aβ Binding Agents

P. Aisen, W. Klunk, C. Mathis, 2005 .

Human Biodistribution and Dosimetry of the PET Radioligand [11C]Flumazenil (FMZ)

J. Mountz, C. Laymon, C. Mathis, 2012, Molecular Imaging and Biology.

OPL204 Amyloid imaging in Lewy Body Dementia with 11C-PIB-PET

C. Rowe, C. Masters, C. Mathis, 2005, Journal of the Neurological Sciences.

Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain.

W. Klunk, C. Mathis, Y. Wang, 2004, Current pharmaceutical design.

PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS.

S. Wisniewski, C. Mathis, C. Meltzer, 2004, The Journal of clinical investigation.

[11C]WAY 100635: a radioligand for imaging 5-HT1A receptors with positron emission tomography.

M. Mintun, Paul Kinahan, C. Mathis, 1994, Life sciences.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2018, Anesthesiology.

Characterizing the emergence of amyloid and tau burden in Down syndrome.

Sterling C. Johnson, Matthew D. Zammit, D. Minhas, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

An Abeta sequestration approach using non-antibody Abeta binding agents.

P. Aisen, C. Mathis, M. Debnath, 2005, Current Alzheimer Research.

P-029 Correlation of regional in VIVO pittsburgh compound-B (PIB) retention with in vitro PIB, Aβ levels, and amyloid plaque density: Validation of PIB-PET in postmortem human brain

S. DeKosky, W. Klunk, C. Mathis, 2007, Alzheimer's & Dementia.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Longitudinal PIB measures in control, MCI, and AD subjects

S. DeKosky, W. Klunk, C. Mathis, 2008 .

Simplified quantification of PIB amyloid imaging PET studies

S. DeKosky, W. Klunk, C. Mathis, 2005 .

Amyloid imaging with Pittsburgh Compound-B in late-life depression

C. Reynolds, S. DeKosky, W. Klunk, 2005, Alzheimer's & Dementia.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2020, Scientific Reports.

Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging

A. Saykin, S. Risacher, O. Lopez, 2018, Molecular Psychiatry.

Low thalamic activity during a digit-symbol substitution task is associated with symptoms of subjective cognitive decline

W. Klunk, C. Mathis, B. Snitz, 2023, Frontiers in psychiatry.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

David T. Jones, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies

D. Minhas, W. Klunk, C. Mathis, 2023, The Journal of Nuclear Medicine.

A Novel Brain PET Radiotracer for Imaging Alpha Synuclein Fibrils in Multiple System Atrophy.

Virginia M. Y. Lee, R. Mach, C. Mathis, 2023, Journal of Medicinal Chemistry.

11C-PiB PET can underestimate brain amyloid-β burden when cotton wool plaques are numerous.

B. Ghetti, W. Klunk, C. Mathis, 2021, Brain : a journal of neurology.

Tiagabine Increases [11C]flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects

R. Cho, C. Mathis, R. Narendran, 2009, Neuropsychopharmacology.

BINDING OF PITTSBURGH COMPOUND B TO BOTH NORMAL AND ABNORMAL WHITE MATTER IN ELDERLY COGNITIVELY NORMAL CONTROL

D. Minhas, W. Klunk, C. Mathis, 2014, Alzheimer's & Dementia.

Human amyloid-imaging studies with Pittsburgh Compound-B in mild cognitive impairment (MCI): Is MCI the critical period of amyloid plaque deposition?

S. DeKosky, W. Klunk, C. Mathis, 2005, Alzheimer's & Dementia.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

Jeffrey A. James, S. DeKosky, P. Houck, 2008, Archives of neurology.

Amyloid imaging in mild cognitive impairment subtypes

Jeffrey A. James, O. Lopez, S. DeKosky, 2009, Annals of neurology.

Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals.

Jeffrey A. James, D. Minhas, O. Lopez, 2015, JAMA neurology.

Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects.

W. Klunk, C. Mathis, B. Snitz, 2014, Brain : a journal of neurology.

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

Keith A. Johnson, D. Minhas, M. Mintun, 2015, Alzheimer's & Dementia.

Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue

Keith A. Johnson, B. Dickerson, J. Growdon, 2015, Annals of neurology.

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

C. Jack, M. Weiner, A. Toga, 2010, Neurobiology of Aging.

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease

S. DeKosky, W. Klunk, C. Mathis, 2008, NeuroImage.

Effects of soy isoflavones on cognitive function: a systematic review and meta-analysis of randomized controlled trials.

C. Mathis, B. Snitz, H. Aizenstein, 2019, Nutrition reviews.

SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0

N. Bohnen, J. Seibyl, C. Mathis, 2016, The Journal of Nuclear Medicine.

Association between Brain Amyloid, White Matter Hyperintensities and Hypometabolism, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals.

W. Klunk, C. Mathis, B. Snitz, 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old

J. Becker, L. Kuller, O. Lopez, 2014, Neurology.

Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET

Bedda L. Rosario, Jeffrey A. James, C. Laymon, 2010, NeuroImage.

IC–103–05: Pittsburgh compound–B four years later: What have we learned, what lies ahead?

William E. Klunk, Chester A. Mathis, Julie C. Price, 2006 .

IC-P-016 Imaging of cerebral amyloid angiopathy with Pittsburgh compound B

S. DeKosky, W. Klunk, C. Mathis, 2006, Alzheimer's & Dementia.

IC–103–04: Amyloid burden correlates with cognitive function in normal aging, MCI and AD

R. Sperling, S. DeKosky, W. Klunk, 2006 .

ORAL SESSIONS: IC-O3 EMERGING TECHNIQUES IC-O3-01 THE CENTILOID SCALE: STANDARDIZATION OF AMYLOID IMAGING MEASURES

Keith A. Johnson, M. Mintun, W. Jagust, 2013 .